Homozygous 23-bp insertion of endothelial protein C receptor gene in a child with fatal sepsis

Pediatric Hematology and Oncology

Volumn 24, Issue 3, 2007, Pages 199-204

  Kendirli, Tanil ^a   Çiftçi, Ergin ^a   Ince, Erdal ^a   Yurdakul, Engin ^a   Kansu, Aydan ^a   Akar, Nejat ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Child; Endothelial protein C receptor; Homozygous 23 bp insertion; Sepsis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ENDOTHELIAL PROTEIN C RECEPTOR; FLUCONAZOLE; SULTAMICILLIN; THROMBOMODULIN; VANCOMYCIN;

ARTICLE; CANDIDA ALBICANS; CASE REPORT; CHRONIC LIVER DISEASE; ENDOTHELIAL PROTEIN C RECEPTOR GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL HEMORRHAGE; GENE; GENE INSERTION; GENETIC ASSOCIATION; HEMOPERITONEUM; HOMOZYGOSITY; HUMAN; INFANT; INTENSIVE CARE; LUNG HEMORRHAGE; MALE; SEPSIS; STAPHYLOCOCCUS AUREUS; THALASSEMIA MAJOR; TREATMENT OUTCOME;

ANTIGENS, CD; BACTEREMIA; CANDIDA ALBICANS; ENDOTHELIUM, VASCULAR; FATAL OUTCOME; FUNGEMIA; GASTROINTESTINAL HEMORRHAGE; HOMOZYGOTE; HUMANS; INFANT; MALE; MUTAGENESIS, INSERTIONAL; RECEPTORS, CELL SURFACE; STAPHYLOCOCCUS AUREUS;

EID: 34247549228     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010701198811     Document Type: Article

References (23)

1. Esmon CT. The protein C pathway. Chest. 2003;124:26S-32S.
2. Wouwer MV, Collen D, Conway EM. Thrombomodulin-protein C-EPCR system integrated to regulate coagulation and inflammation. Arterioscler Thromb Vasc Biol. 2004;24:1374-1383.
3. Li W, Zheng X, Gu J, et al. Overexpressing endothelial cell protein C receptor alters the hemostatic balance and protects mice from endotoxin. J Thromb Haemost. 2005;3:1351-1359.
4. Raide TJ, Lentz SR. The benefits of excess EPCR. J Thromb Haemost. 2005;3:1349-1350.
5. Stearns-Kurosawa DJ, Swindle K, D'Angelo A, et al. Plasma levels of endothelial protein C respond to anticoagulant treatment. Blood. 2002;99:526-530.
6. Sipahi T, Pocan H, Akar N. Effect of various genetic polymorphisms on the incidence and outcome of severe sepsis. Clin Appl Thromb Hemost. 2006;12:47-54.
7. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2-8.
8. Dahmer KM, Randolph A, Vitali S, Quasney MW. Genetic polymorphism in sepsis. Pediatr Crit Care Med. 2005; 6(Suppl):S61-S73.
9. Liaw PCY, Neuenschwander PF, Smirnov MD, Esmon CT. Mechanisms by which soluble endothelial protein C receptor modulates protein C and activated protein C function. J Biol Chem. 2000;275;5447-5452.
10. Regan LM, Stearns-Kurosawa DJ, Kurosawa S, Mollica J, Fukudome K, Esmon CT. The endothelial protein C receptor. J Biol Chem. 2000;271;17499- 17503.
11. Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ. Expression and function of the endothelial protein C receptor in human neutrophils. Blood. 2003;102:1499-1505.
12. Gu JM, Crawley JT, Ferrell G, et al. Distruption of the endothelial cell protein C receptor gene in mice causes placental thrombosis and early embryonic lethality. J Biol Chem. 2002;277:43335-43343.
13. Biguzzi E, Merati G, Liaw PC, et al. A 23 bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost. 2001;86:945-948.
14. Taylor FB, Stearns-Kurosawa DJ, Kurosawa S, et al. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood. 2000;95:1680-1686.
15. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001; 344:699-709.
16. Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndome. Blood. 2003;101:3765-3777.
17. Liaw PCY, Esmon CT, Kahnamoui K, et al. Patients with severe sepsis vary markedly in their ability to generate activated protein C. Blood. 2004;104:3958-3964.
18. White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood. 2000;96:3719-3724.
19. Akar N, G̈okdemir R, Ozel D, Akar E. Endothelial cell protein C receptor (EPCR) gene exon III, 23 bp insertion mutation in the Turkish pediatric thrombotic patients. Thromb Haemost. 2002;88:1068-1069.
20. Goldstein B, Nadel S, Peters M, et al. ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with sepsis. Pediatr Crit Care Med. 2006;7:200-211.
21. Derhaschnig U, Reiter R, Kn̈oble P, Baumgartner M, Keen P, Jilma B. Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia. Blood. 2003;102:2093-2098.
22. Weitz JI. Neutropils and the protein C patway. Blood. 2003;102:1152-1153.
23. Dellinger RP, Carlet JM, Masur H, et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Intense Care Med. 2004;30:536-555.